project . 2015 - 2020 . Closed

A UK Hub to Catalyse Open Target Discovery.

Wellcome Trust
  • Funder: Wellcome TrustProject code: 106169
  • Funded under: Molecular Basis of Cell Function Funder Contribution: 9,000,000 GBP
  • Status: Closed
  • Start Date
    01 Jul 2015
    End Date
    30 Jun 2020
Description
Ageing societies and diseases of modern living require truly novel, efficacious and safe medicines. Increasing investment in R&D has not improved the efficiency of this endeavor. There is an urgent need for novel, validated drug targets. To facilitate this, the Wellcome Trust and other organisations have sponsored large-scale genome-wide association and sequencing studies in patients, identifying thousands of genes linked to human disease, some of which may become targets for pioneer drug disco very. However, this genetic output is not widely exploited because of the lack of data and research tools to prioritise targets. The SGC was created by the Wellcome Trust...
Description
Ageing societies and diseases of modern living require truly novel, efficacious and safe medicines. Increasing investment in R&D has not improved the efficiency of this endeavor. There is an urgent need for novel, validated drug targets. To facilitate this, the Wellcome Trust and other organisations have sponsored large-scale genome-wide association and sequencing studies in patients, identifying thousands of genes linked to human disease, some of which may become targets for pioneer drug disco very. However, this genetic output is not widely exploited because of the lack of data and research tools to prioritise targets. The SGC was created by the Wellcome Trust...
Any information missing or wrong?Report an Issue